Liu Hui
Förmögenhet: 207 157 $ per 2026-09-30
Förmögenhet: 207 157 $ per 2026-09-30
Dr. Liu Hui is an Independent Director at Rallybio Corp.
He is on the Board of Directors at Rallybio Corp.
Dr. Hui was previously employed as a Chief Business Officer & Executive Vice President by Merus NV and a VP & Head-Business Development & Licensing by Novartis AG.
He received his undergraduate degree from Peking University, an MBA from the University of Michigan and a doctorate degree from the University of Michigan.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
RALLYBIO CORPORATION 0,23 % | 2026-09-24 | 12 044 ( 0,23 % ) | 207 157 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| RALLYBIO CORPORATION | Direktör/Styrelseledamot | 2022-04-04 |
| Företag | Position | Slut |
|---|---|---|
| MERUS N.V. | Företagsledare/Principal | 2024-07-01 |
| NOVARTIS AG | Företagsledare/Principal | 2015-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merus NV
Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån